Bone Health For Life
Bone Care For Life

Web Search Site


Menu Spacer

Osteoporosis Clinical Practice Guidelines

Organization (Date )

Who Should be Tested?

North American Menopause Society (2002)

•  All women with medical causes of bone loss and in those who are at least 65 years of age, regardless of additional risk factors.

•  All postmenopausal women younger than age 65 with one or more of the following risk factors for fracture: a nonvertebral fracture after menopause, low body weight (<127 lbs), or a history of a first-degree relative who has experienced a hip or vertebral fracture.

•  Early postmenopausal women to assist with a decision about preventive therapy.

•  Premenopausal women who experience a low-trauma fracture or who have known secondary causes of osteoporosis.

American Association of Clinical Endocrinologists (2001)

•  Perimenopausal or postmenopausal women who have risk factors for fractures and are willing to consider available interventions.

•  Women who have X-ray findings that suggest osteoporosis.

•  Women beginning or receiving long-term glucocorticoid therapy or other drugs associated with bone loss.

•  All adult women with symptomatic hyperparathyroidism or other diseases or nutritional conditions associated with bone loss in whom evidence of bone loss would result in adjustment of management.

•  In women receiving treatment for osteoporosis (baseline measurements should be made before intervention.)

•  In all women 40 years or older who have sustained a fracture.

•  In all women beyond 65 years of age.

American College of Obstetricians and Gynecologists (2002)

•  All postmenopausal women who have sustained a fracture.

•  Postmenopausal women under 65 years of age who have one or more risk factors, including a personal history of fracture as an adult, being of Caucausian race, having impaired eyesight despite adequate correction, and having a history of alcoholism.

•  Pre- or post-menopausal women with certain diseases or medical conditions associated with an increased risk for osteoporosis.

National Osteoporosis Foundation (1999)

•  All postmenopausal women under age 65 who have one or more additional risk factors for osteoporotic fracture (besides menopause.)

•  All women aged 65 or older regardless of additional risk factors.

•  Postmenopausal women who present with fractures.

•  Women who are considering therapy for osteoporosis, if BMD testing would facilitate the decision.

•  Women who have been on hormone replacement therapy for prolonged periods.

© 2004 U.S. Foods and Pharmaceuticals, Inc. All rights reserved. 800-362-8294